Nath Bio-Genes (India) Limited (BOM:537291)

Nath Bio-Genes (India) Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	7.42	888.99	774.1	379.95	41.81	292.16
Cash & Short-Term Investments	7.42	888.99	774.1	379.95	41.81	292.16
Cash Growth	-64.25%	14.84%	103.73%	808.85%	-85.69%	32.89%
Accounts Receivable	1,794	889.02	943.09	973.14	855.48	1,094
Other Receivables	75.11	72.71	64.08	63.68	71.79	73.96
Receivables	2,364	961.72	1,007	1,037	927.27	1,168
Inventory	3,080	3,380	2,303	2,078	2,203	2,263
Prepaid Expenses	-	4.29	2.9	3.6	3.48	2.8
Other Current Assets	1,613	1,665	1,629	1,699	1,502	1,635
Total Current Assets	7,064	6,900	5,717	5,198	4,678	5,361
Property, Plant & Equipment	2,431	2,432	2,406	2,340	2,329	2,333
Long-Term Investments	58.31	57.82	60.46	50.48	50.48	50.48
Other Intangible Assets	64.34	71.82	88.12	104.17	120.26	136.19
Other Long-Term Assets	394.1	442.16	421.59	235.4	217.86	14.35
Total Assets	10,142	10,262	8,802	7,928	7,395	7,895
Accounts Payable	693.24	794.84	432.96	277.36	427.82	264.43
Accrued Expenses	6.84	139.11	104.31	97.99	117	110.45
Short-Term Debt	1,406	48.78	49.12	10.33	18.84	121.47
Current Portion of Long-Term Debt	-	1,046	1,006	1,038	904.1	879.79
Current Income Taxes Payable	16.91	3.9	9.47	2.81	8.87	25.31
Current Unearned Revenue	-	1,142	645.95	513.23	238.37	220.36
Other Current Liabilities	1,043	478.42	376.96	224.87	227.91	108.23
Total Current Liabilities	3,166	3,653	2,624	2,164	1,943	1,730
Long-Term Debt	142.02	129.76	48.65	4.03	6.65	6.53
Pension & Post-Retirement Benefits	35.06	35.43	30	22.35	18.39	20.05
Other Long-Term Liabilities	-	-	-0	5.52	7.71	5.69
Total Liabilities	3,343	3,818	2,703	2,196	1,976	1,762
Common Stock	190.04	190.04	190.04	190.04	190.04	190.04
Additional Paid-In Capital	-	1,335	1,335	1,335	1,335	1,335
Retained Earnings	-	4,792	4,444	4,086	3,774	4,486
Comprehensive Income & Other	6,608	126.4	129.7	120.43	120.22	121.93
Total Common Equity	6,799	6,444	6,099	5,732	5,419	6,133
Minority Interest	-	-	-	-	-0.05	-
Shareholders' Equity	6,799	6,444	6,099	5,732	5,419	6,133
Total Liabilities & Equity	10,142	10,262	8,802	7,928	7,395	7,895
Total Debt	1,548	1,225	1,103	1,052	929.59	1,008
Net Cash (Debt)	-1,541	-336.01	-329.36	-672.17	-887.78	-715.63
Net Cash Per Share	-81.20	-17.68	-17.33	-35.37	-46.72	-37.66
Filing Date Shares Outstanding	19.67	19	19	19	19	19
Total Common Shares Outstanding	19.67	19	19	19	19	19
Working Capital	3,898	3,247	3,092	3,034	2,735	3,631
Book Value Per Share	345.69	339.08	320.94	301.61	285.16	322.71
Tangible Book Value	6,734	6,372	6,011	5,628	5,299	5,997
Tangible Book Value Per Share	342.42	335.30	316.31	296.12	278.84	315.54
Land	-	2,225	2,221	2,221	2,221	2,221
Buildings	-	60.52	48.67	33.78	31.28	31.02
Machinery	-	342.95	311.9	280.98	260.2	260.47

Source: S&P Global Market Intelligence. Standard template. Financial Sources.